Clarapath, a robotics company for pathology lab processing, raised a $36 million Series B-1 led by Northwell Ventures, CEO Eric Feinstein tells Axios exclusively.
Why it matters: The laboratory staffing shortage got worse during COVID, and new technologists aren't being trained at the rate required to replace outgoing workers.
